SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-079597
Filing Date
2010-08-20
Accepted
2010-08-20 16:13:36
Documents
4
Period of Report
2010-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c05128e10vq.htm 10-Q 244549
2 EXHIBIT 31.1 c05128exv31w1.htm EX-31.1 9701
3 EXHIBIT 31.2 c05128exv31w2.htm EX-31.2 9674
4 EXHIBIT 32.1 c05128exv32w1.htm EX-32.1 5143
  Complete submission text file 0000950123-10-079597.txt   270498
Mailing Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121
Business Address 4365 EXECUTIVE DRIVE, SUITE 300 SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24274 | Film No.: 101030357
SIC: 2836 Biological Products, (No Diagnostic Substances)